NAURA(002371)2025-05-21 10:23Investment Rating - The report maintains a "Buy" rating for the company [8] Core Views - The company achieved a revenue of 8.2 billion yuan in Q1 2025, representing a year-on-year increase of 38% and a quarter-on-quarter decrease of 13%. The net profit attributable to the parent company was 1.6 billion yuan, up 39% year-on-year and up 36% quarter-on-quarter [5] - In 2024, the company is projected to achieve a revenue of 29.8 billion yuan, a year-on-year increase of 35%, with a net profit of 5.6 billion yuan, up 44% year-on-year [5] - The company's electronic process equipment revenue for 2024 is expected to reach 27.7 billion yuan, a year-on-year increase of 41%, with significant growth in various equipment segments [6] - The company officially entered the ion implantation equipment market in March 2025, launching its first ion implantation machine, Sirius MC 313, enhancing its competitiveness in the semiconductor manufacturing market [7] Financial Summary - The company’s projected net profits for 2025, 2026, and 2027 are 7.71 billion yuan, 9.42 billion yuan, and 11.73 billion yuan, respectively, with corresponding EPS of 14.44 yuan, 17.63 yuan, and 21.96 yuan [8] - The projected revenue for the company from 2024 to 2027 shows a consistent growth trend, with revenues of 29.8 billion yuan, 39.7 billion yuan, 49.2 billion yuan, and 60.9 billion yuan, respectively [9] - The gross margin is expected to remain stable around 42% over the forecast period, indicating strong profitability [9]